A pragmatic approach to sonothrombolysis in acute ischaemic stroke: The Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)

BMC Neurology

Volumn 15, Issue 1, 2015, Pages

  Nacu, Aliona ^a,b   Kvistad, Christopher E ^a,b   Logallo, Nicola ^a   Naess, Halvor ^a,b,c   Waje Andreassen, Ulrike ^a   Aamodt, Anne Hege ^d   Solhoff, Ragnar ^e   Lund, Christian ^d   Tobro, Håkon ^f   Rønning, Ole Morten ^g   Salvesen, Rolf ^h   Idicula, Titto T ⁱ   Thomassen, Lars ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Section for Gastroenterology   (Norway)

^f Skien Municipality   (Norway)

^g AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^h Department of Paediatrics   (Norway)

ⁱ TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute ischemic stroke; Arterial occlusion; Contrast; Outcome; Randomised controlled trial; Recanalisation; Safety; Sonolysis; Sonothrombolysis; Thrombolysis; Transcranial ultrasound

Indexed keywords

ALTEPLASE; SONOVUE; TENECTEPLASE; CONTRAST MEDIUM; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ARTERY OCCLUSION; ARTICLE; BRAIN ISCHEMIA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FIBRINOLYTIC THERAPY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SONOTHROMBOLYSIS; STROKE PATIENT; SYMPTOM; TREATMENT CONTRAINDICATION; ULTRASOUND; ULTRASOUND THERAPY; CLINICAL TRIAL; MICROBUBBLE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PROCEDURES; STROKE;

BRAIN ISCHEMIA; COMBINED MODALITY THERAPY; CONTRAST MEDIA; FIBRINOLYTIC AGENTS; HUMANS; MICROBUBBLES; STROKE; TISSUE PLASMINOGEN ACTIVATOR; ULTRASONIC THERAPY;

EID: 84936871720     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-015-0359-4     Document Type: Article

References (70)

1. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-29.
2. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32(1):78-86.
3. van der Worp HB, van Gijn J. Clinical practice. Acute ischemic stroke. N Engl J Med. 2007;357(6):572-9.
4. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke; J Cerebral Circulation. 2006;37(2):425-9.
5. Stone MJ, Frenkel V, Dromi S, Thomas P, Lewis RP, Li KC, et al. Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study. Thromb Res. 2007;121(2):193-202.
6. Frenkel V, Oberoi J, Stone MJ, Park M, Deng C, Wood BJ, et al. Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model. Radiology. 2006;239(1):86-93.
7. Polak JF. Ultrasound energy and the dissolution of thrombus. N Engl J Med. 2004;351(21):2154-5.
8. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351(21):2170-8.
9. Behrens S, Spengos K, Daffertshofer M, Wirth S, Hennerici M. Potential use of therapeutic ultrasound in ischemic stroke treatment. Echocardiography. 2001;18(3):259-63.
10. Spengos K, Behrens S, Daffertshofer M, Dempfle CE, Hennerici M. Acceleration of thrombolysis with ultrasound through the cranium in a flow model. Ultrasound Med Biol. 2000;26(5):889-95.
11. Skoloudik D, Fadrna T, Roubec M, Bar M, Zapletal O, Blatny J, et al. Changes in hemocoagulation in acute stroke patients after one-hour sono-thrombolysis using a diagnostic probe. Ultrasound Med Biol. 2010;36(7):1052-9.
12. Daffertshofer M, Hennerici M. Ultrasound in the treatment of ischaemic stroke. Lancet Neurol. 2003;2(5):283-90.
13. Hynynen K, Clement G. Clinical applications of focused ultrasound-the brain. Int J Hyperth: Off J Euro Soc Hyperthermic Onco North Am Hyperthermia Group. 2007;23(2):193-202.
14. Hynynen K. Focused ultrasound for blood-brain disruption and delivery of therapeutic molecules into the brain. Expert Opin Drug Deliv. 2007;4(1):27-35.
15. Tang SC, Clement GT. Standing-wave suppression for transcranial ultrasound by random modulation. IEEE Trans Biomed Eng. 2010;57(1):203-5.
16. Daffertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke; J Cerebral Circulation. 2005;36(7):1441-6.
17. Meairs S, Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol. 2007;93(1-3):354-62.
18. Xie F, Tsutsui JM, Lof J, Unger EC, Johanning J, Culp WC, et al. Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis. Ultrasound Med Biol. 2005;31(7):979-85.
19. Tsivgoulis G, Eggers J, Ribo M, Perren F, Saqqur M, Rubiera M, et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke; J Cerebral Circulation. 2010;41(2):280-7.
20. Ricci S, Dinia L, Del Sette M, Anzola P, Mazzoli T, Cenciarelli S, et al. Sonothrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2012;6, CD008348.
21. Barreto AD, Sharma VK, Lao AY, Schellinger PD, Amarenco P, Sierzenski P, et al. Safety and dose-escalation study design of transcranial ultrasound in clinical SONolysis for acute ischemic stroke: the TUCSON trial. Int J Stroke: Off J Intl Stroke Soc. 2009;4(1):42-8.
22. Molina CA, Barreto AD, Tsivgoulis G, Sierzenski P, Malkoff MD, Rubiera M, et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol. 2009;66(1):28-38.
23. Eggers J, Konig IR, Koch B, Handler G, Seidel G. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke; J Cerebral Circulation. 2008;39(5):1470-5.
24. de Saint VM, Crake C, Coussios CC, Stride E. Properties, characteristics and applications of microbubbles for sonothrombolysis. Expert Opin Drug Deliv. 2014;11(2):187-209.
25. Wang B, Wang L, Zhou XB, Liu YM, Wang M, Qin H, et al. Thrombolysis effect of a novel targeted microbubble with low-frequency ultrasound in vivo. J Thromb Haemost. 2008;100(2):356-61.
26. Culp WC, Porter TR, Lowery J, Xie F, Roberson PK, Marky L. Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke; J Cerebral Circulation. 2004;35(10):2407-11.
27. Tsivgoulis G, Culp WC, Alexandrov AV. Ultrasound enhanced thrombolysis in acute arterial ischemia. Ultrasonics. 2008;48(4):303-11.
28. Weiss HL, Selvaraj P, Okita K, Matsumoto Y, Voie A, Hoelscher T, et al. Mechanical clot damage from cavitation during sonothrombolysis. J Acoust Soc Am. 2013;133(5):3159-75.
29. Vignon F, Shi WT, Powers JE, Everbach EC, Liu J, Gao S, et al. Microbubble cavitation imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2013;60(4):661-70.
30. Everbach EC, Francis CW. Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz. Ultrasound Med Biol. 2000;26(7):1153-60.
31. Hitchcock KE, Holland CK. Ultrasound-assisted thrombolysis for stroke therapy: better thrombus break-up with bubbles. Stroke; J Cerebral Circulation. 2010;41(10 Suppl):S50-3.
32. Datta S, Coussios CC, Ammi AY, Mast TD, de Courten-Myers GM, Holland CK. Ultrasound-enhanced thrombolysis using definity as a cavitation nucleation agent. Ultrasound Med Biol. 2008;34(9):1421-33.
33. Datta S, Coussios CC, McAdory LE, Tan J, Porter T, De Courten-Myers G, et al. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol. 2006;32(8):1257-67.
34. Ammi AY, Mast TD, Huang IH, Abruzzo TA, Coussios CC, Shaw GJ, et al. Characterization of ultrasound propagation through ex-vivo human temporal bone. Ultrasound Med Biol. 2008;34(10):1578-89.
35. Nedelmann M, Ritschel N, Doenges S, Langheinrich AC, Acker T, Reuter P, et al. Combined contrast-enhanced ultrasound and rt-PA treatment is safe and improves impaired microcirculation after reperfusion of middle cerebral artery occlusion. J Cereb Blood Flow Metab: Off J Intl Soc Cerebral Blood Flow Metabolism. 2010;30(10):1712-20.
36. Stride E. Physical principles of microbubbles for ultrasound imaging and therapy. Cerebrovasc Dis. 2009;27 Suppl 2:1-13.
37. Cintas P, Le Traon AP, Larrue V. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke; J Cerebral Circulation. 2002;33(2):626-8.
38. Eggers J, Seidel G, Koch B, Konig IR. Sonothrombolysis in acute ischemic stroke for patients ineligible for rt-PA. Neurology. 2005;64(6):1052-4.
39. Meairs S, Alonso A, Hennerici MG. Progress in sonothrombolysis for the treatment of stroke. Stroke; J Cerebral Circulation. 2012;43(6):1706-10.
40. Kuliha M, Roubec M, Fadrná T, Saňak D, Herzig R, Jonszta T, et al. Endovascular sono-lysis using EKOS system in acute stroke patients with a main cerebral artery occlusion - a pilot study. Perspect Med. 2012;1(1-12):65-72.
41. Meairs S, Alonso A, Fatar M, Kern R, Hennerici M. Microbubbles traversing the blood-brain barrier for imaging and therapy. Med Biol Eng Comput. 2009;47(8):839-49.
42. Yepes M, Roussel BD, Ali C, Vivien D. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci. 2009;32(1):48-55.
43. Haley Jr EC, Thompson JL, Grotta JC, Lyden PD, Hemmen TG, Brown DL, et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke; J Cerebral Circulation. 2010;41(4):707-11.
44. Meretoja A, Tatlisumak T. Novel thrombolytic drugs: will they make a difference in the treatment of ischaemic stroke? CNS Drugs. 2008;22(8):619-29.
45. Haley Jr EC, Lyden PD, Johnston KC, Hemmen TM, Investigators TiS. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke; J Cerebral Circulation. 2005;36(3):607-12.
46. Ricci S, Dinia L, Del Sette M, Anzola P, Mazzoli T, Cenciarelli S, et al. Sonothrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2012;10, CD008348.
47. Joung-Ho R, Saver JL. The impact of recanalization on ischemic stroke outcome. A meta-analysis. Stroke; J Cerebral Circulation. 2007;38:967-73.
48. Saqqur M, Tsivgoulis G, Nicoli F, Skoloudik D, Sharma VK, Larrue V, et al. The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging: Off J Am Soc Neuroimaging. 2014;24(3):209-20.
49. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta stroke programme early CT score. Lancet. 2000;355(9216):1670-4.
50. Zanette EM, Fieschi C, Bozzao L, Roberti C, Toni D, Argentino C, et al. Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke. Stroke; J Cerebral Circulation. 1989;20(7):899-903.
51. Alexandrov AV, Demchuk AM, Burgin WS, Robinson DJ, Grotta JC, Investigators C. Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. J Neuroimaging: Off J Am Soc Neuroimaging. 2004;14(2):113-7.
52. Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, et al. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke; J Cerebral Circulation. 2001;32(1):89-93.
53. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, Gass A, Nolte C, Kucinski T, et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke; J Cerebral Circulation. 2004;35(1):109-14.
54. Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, et al. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet. 2008;371(9621):1353-63.
55. Coutts SB, Lev MH, Eliasziw M, Roccatagliata L, Hill MD, Schwamm LH, et al. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke; J Cerebral Circulation. 2004;35(11):2472-6.
56. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: safe implementation of thrombolysis in stroke-MOnitoring STudy (SITS-MOST). Stroke; J Cerebral Circulation. 2008;39(12):3316-22.
57. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768-74.
58. Larrue V, von Kummer RR, Müller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke; J Cerebral Circulation. 2001;32:438-41.
59. de Los Rios la Rosa F, Khoury J, Kissela BM, Flaherty ML, Alwell K, Moomaw CJ, et al. Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European cooperative acute stroke study (ECASS) III trial. Stroke; J Cerebral Circulation. 2012;43:1591-5.
60. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet. 2007;369(9558):275-82.
61. Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9(9):866-74.
62. Sylaja PN, Cote R, Buchan AM, Hill MD, Canadian Alteplase for Stroke Effectiveness Study I. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian alteplase for stroke effectiveness study. J Neurol Neurosurg Psychiatry. 2006;77(7):826-9.
63. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke; J Cerebral Circulation. 2007;38(3):967-73.
64. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol. 2004;61(7):1066-70.
65. Behrens S, Spengos K, Daffertshofer M, Schroeck H, Dempfle CE, Hennerici M. Transcranial ultrasound-improved thrombolysis: diagnostic vs. therapeutic ultrasound. Ultrasound Med Biol. 2001;27(12):1683-9.
66. Baron C, Aubry JF, Tanter M, Meairs S, Fink M. Simulation of intracranial acoustic fields in clinical trials of sonothrombolysis. Ultrasound Med Biol. 2009;35(7):1148-58.
67. Stroick M, Alonso A, Fatar M, Griebe M, Kreisel S, Kern R, et al. Effects of simultaneous application of ultrasound and microbubbles on intracerebral hemorrhage in an animal model. Ultrasound Med Biol. 2006;32(9):1377-82.
68. Saqqur M, Tsivgoulis G, Nicoli F, Skoloudik D, Sharma VK, Larrue V, et al. The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging: Off J Am Soc Neuroimaging. 2013. doi: 10.1111/jon.12026.
69. Unger EC, Matsunaga TO, McCreery T, Schumann P, Sweitzer R, Quigley R. Therapeutic applications of microbubbles. Eur J Radiol. 2002;42(2):160-8.
70. Logallo N, Kvistad CE, Naess H, Waje-Andreassen U, Thomassen L. Mild stroke: safety and outcome in patients receiving thrombolysis. Acta Neurol Scand Suppl. 2014;198:37-40.